Pacific Biosciences of California, Inc. - Common Stock (PACB)

$1.56 0.00 (0.00%)

16:00 EST PACB Stock Quote Delayed 30 Minutes

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings Aug 7, 2024

PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024

The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

Volume:

Previous Close -

Market Cap 385.44M

PE Ratio -1.07

EPS -1.46

Volume (Avg. Vol.) 8,959

Day's Range -

52-Week Range $1.16 - $6.09

Dividend & Yield N/A (N/A)

PACB Stock Predictions, Articles, and Pacific Biosciences of California, Inc. - Common Stock News

7 Stocks Cathie Wood Is Still Loading Up On in Q1

By Rich Duprey, InvestorPlace Contributor Feb 13, 2024

You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.

The 3 Best Cathie Wood Stocks to Buy in December

By Larry Ramer, InvestorPlace Contributor Dec 10, 2023

Cathie Wood stocks had a great November and are well-positioned to keep performing well, given the favorable macro backdrop.

Why Is Pacific Biosciences (PACB) Stock Up 5% Today?

By Chris MacDonald, InvestorPlace Contributor Aug 11, 2022

Shareholders in Pacific Biosciences and PACB stock certainly have a lot to cheer today, as investors go wild for biotech companies.

5 Top Stocks Cathie Wood Bought This Week

By Eddie Pan, InvestorPlace Financial News Writer Aug 5, 2022

Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 11, 2022

Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!

4 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 29, 2016

This week, the ratings of 4 Life Sciences Tools & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Awful Earnings Growth — DK ITG PACB ADPT ORBC

By Portfolio Grader Dec 27, 2016

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

11 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 22, 2016

The overall ratings of 11 Life Sciences Tools & Services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Awful Earnings Growth — DK ITG PACB ADPT ORBC

By Portfolio Grader Dec 20, 2016

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Ugly Earnings Growth — ITG PACB ADPT ORBC RELY

By Portfolio Grader Dec 6, 2016

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 1, 2016

The ratings of 5 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Awful Earnings Growth — EMG ITG PACB ADPT ORBC

By Portfolio Grader Nov 29, 2016

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Nov 24, 2016

This week, the ratings of 5 Life Sciences Tools & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Stocks Rise to New Records Ahead of Jobs Report

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 6, 2014

Tesla Motors Inc, General Electric Company were among Thursday's winners. Next, expect Friday's session to be dominated by the release of the October payroll report.

5 Red-Hot Biotech Stocks to Buy

By Anthony Mirhaydari, InvestorPlace Market Strategist Oct 27, 2014

Investors have been chasing risk again, buying up biotech stocks. Here's our list of the best biotech stocks out there.

Pacific Biosciences of California, Inc. - Common Stock (PACB)

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024

The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pacific Biosciences of California, Inc. - Common Stock (PACB)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PACB Stock Predictions, Articles, and Pacific Biosciences of California, Inc. - Common Stock News

Subscriber Sign in